To build upon these results and examine its validity in human breast cancer tumor samples, we investigated PRLR and CCN2 gene expression profiles in the breast cancer SCAN-B (n = 3207) and METABRIC (n = 1992) cohorts (Fig. 3D, upper and middle panels). This evidence concerns the gene PRLR and breast carcinoma.